Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Sell
6,412
-706
-10% -$1.12M 0.26% 87
2026
Q1
$9.4M Sell
7,118
-1,348
-16% -$1.85M 0.22% 103
2025
Q4
$9.06M Buy
8,466
+275
+3% +$287K 0.22% 114
2025
Q3
$7.93M Buy
8,191
+1,415
+21% +$1.11M 0.2% 131
2025
Q2
$5.43M Buy
6,776
+4,798
+243% +$3.44M 0.13% 190
2025
Q1
$1.31M Buy
1,978
+423
+27% +$308K 0.04% 396
2024
Q4
$1.08M Buy
1,555
+17
+1% +$12.2K 0.04% 407
2024
Q3
$1.28M Buy
1,538
+1,263
+459% +$1.13M 0.05% 353
2024
Q2
$281K Buy
275
+40
+17% +$38.5K 0.01% 617
2024
Q1
$228K Buy
235
+45
+24% +$39.9K 0.01% 668
2023
Q4
$144K Buy
190
+48
+34% +$31.7K 0.01% 751
2023
Q3
$83.6K Buy
142
+68
+92% +$45.2K ﹤0.01% 921
2023
Q2
$53.6K Buy
74
+28
+61% +$19K ﹤0.01% 1059
2023
Q1
$31.3K Sell
46
-28
-38% -$18K ﹤0.01% 1208
2022
Q4
$40.4K Hold
74
﹤0.01% 1118
2022
Q3
$30K Sell
74
-179
-71% -$89.7K ﹤0.01% 1193
2022
Q2
$113K Sell
253
-3
-1% -$1.68K 0.01% 968
2022
Q1
$170K Buy
256
+8
+3% +$5.36K 0.01% 863
2021
Q4
$197K Buy
248
+42
+20% +$33.4K 0.01% 872
2021
Q3
$152K Hold
206
0.01% 981
2021
Q2
$141K Hold
206
0.01% 1014
2021
Q1
$133K Hold
206
﹤0.01% 1163
2020
Q4
$128K Buy
206
+200
+3,333% +$84.2K 0.01% 1029
2020
Q3
$2K Hold
6
﹤0.01% 2376
2020
Q2
$2K Hold
6
﹤0.01% 2332
2020
Q1
$1K Sell
6
-21
-78% -$5.97K ﹤0.01% 2336
2019
Q4
$8K Buy
27
+21
+350% +$5.67K ﹤0.01% 2037
2019
Q3
$1K Hold
6
﹤0.01% 2362
2019
Q2
$1K Hold
6
﹤0.01% 2370
2019
Q1
$1K Buy
+6
New +$1.06K ﹤0.01% 2296
2018
Q4
Sell
-6
Closed -$1K 2382
2018
Q3
$1K Buy
+6
New +$1.2K ﹤0.01% 2317

Other funds holding ASML

Geneos Wealth Management's ASML Position: Q2 2026 in Review

Geneos Wealth Management reduced its ASML (ASML) stake by 9.9% in Q2 2026, selling an estimated $1.12M and leaving 6,412 shares worth $12.8M. The position accounts for 0.26% of the portfolio, ranked #87.

Geneos Wealth Management first reported a position in ASML in Q3 2018 and has held it in 31 quarters since. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Geneos Wealth Management held 6,412 shares of ASML worth $12.8M as of Q2 2026.
  • Geneos Wealth Management sold 706 ASML shares in Q2 2026, an estimated $1.12M.
  • ASML made up 0.26% of Geneos Wealth Management's portfolio in Q2 2026, its #87 holding.
  • Geneos Wealth Management first reported a position in ASML in Q3 2018 and has held it in 31 quarters since.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.